Skip to main content
40% Launch offerEnds 31 Dec 2026See plans
Kailera Therapeutics, Inc. logo

Kailera Therapeutics, Inc.

GLP-1 Therapies for Obesity Care
WebsiteLinkedIn

Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people living with obesity

Open roles
3
Company size
1 - 50 employees
Headquarters
Waltham, Massachusetts, United States

Follow Kailera Therapeutics, Inc.

Create an exact-company alert for on-site matches and optional daily email.

Open roles